The regulation of class IA PI 3-kinases by inter-subunit interactions

Current Topics in Microbiology and Immunology

Volumn 346, Issue 1, 2010, Pages 87-114

  Backer, Jonathan M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; GUANOSINE TRIPHOSPHATASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPEPTIDE; PROLINE RICH PROTEIN; PROTEIN P110; PROTEIN P110ALPHA SUBUNIT; PROTEIN P110BETA SUBUNIT; PROTEIN P110GAMMA SUBUNIT; PROTEIN P50ALPHA SUBUNIT; PROTEIN P55ALPHA SUBUNIT; PROTEIN P55GAMMA SUBUNIT; PROTEIN P85; PROTEIN P85ALPHA SUBUNIT; PROTEIN P85BETA SUBUNIT; PROTEIN SH3; UNCLASSIFIED DRUG; PROTEIN SUBUNIT;

ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; ENZYME SUBUNIT; GENE MUTATION; HUMAN; IN VIVO STUDY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEOMICS; ANIMAL; CHEMISTRY; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; SRC HOMOLOGY DOMAIN;

ANIMALS; ENZYME ACTIVATION; HUMANS; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; SRC HOMOLOGY DOMAINS;

EID: 79952113796     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-52     Document Type: Article

References (128)

1. Ahmed S, Lee J, Wen L-P, Zhao Z, Ho J, Best A, Kozma R, Lim L (1994) Breakpoint Cluster Region gene product-related domain of n-Chimaerin. J Biol Chem 269:17642-17648
2. Backer JM, Myers MG Jr., Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J et al (1992) Phosphatidylinositol 30-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11(9):3469-3479
3. Bader AG, Kang S, Vogt PK (2006) Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 103(5):1475-1479 (Pubitemid 43191190)
4. Beeton CA, Das P, Waterfield MD, Shepherd PR (1999) The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating Class Ia phosphoinositide 3-kinase function. Mol Cell Biol Res Comm 1:153-157 (Pubitemid 129533207)
5. Beeton CA, Chance EM, Foukas LC, Shepherd PR (2000) Comparison of the kinetic properties of the lipid-and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases. Biochem J 350(Pt 2):353-359
6. Bernado P, Garcia de la Torre J, Pons M (2002) Interpretation of 15N NMR relaxation data of globular proteins using hydrodynamic calculations with HYDRONMR. J Biomol NMR 23(2):139-150 (Pubitemid 34778166)
7. Bokoch GM, Vlahos CJ, Wang Y, Knaus UG, Traynor-Kaplan AE (1996) Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem J 315:775-779 (Pubitemid 26147602)
8. Boldyreff B, Rasmussen TL, Jensen HH, Cloutier A, Beaudet L, Roby P, Issinger OG (2008) Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay. J Biomol Screen 13(10):1035-1040
9. Booker GW, Breeze AL, Downing AK, Panayotou G, Gout I, Waterfield MD, Campbell LD (1992) Structure of an SH2 domain of the p85a subunit of phosphatidylinositol-3 OH-kinase. Nature 358:684-687
10. Brachmann SM, Ueki K, Engelman JA, Kahn RC, Cantley LC (2005) Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol Cell Biol 25(5):1596-1607 (Pubitemid 40282598)
11. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S (1991) Oncogenes and signal transduction. Cell 64:231-302
12. Carpenter CL, Auger KR, Chanudhuri M, Yoakim M, Schaffhausen B, Shoelson S, Cantley LC (1993) Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem 268(13):9478-9483 (Pubitemid 23146000)
13. Carson JD, Van Aller G, Lehr R, Sinnamon RH, Kirkpatrick RB, Auger KR, Dhanak D, Copeland RA, Gontarek RR, Tummino PJ, Luo L (2008) Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase. Biochem J 409(2):519-524 (Pubitemid 351184970)
14. CGART (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
15. Chamberlain MD, Berry TR, Pastor MC, Anderson DH (2004) The p85alpha subunit of phosphatidylinositol 30-kinase binds to and stimulates the GTPase activity of Rab proteins. J Biol Chem 279(47):48607-48614 (Pubitemid 39625735)
16. Chan TO, Rodeck U, Chan AM, Kimmelman AC, Rittenhouse SE, Panayotou G, Tsichlis PN (2002) Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell 1(2):181-191 (Pubitemid 41039164)
17. Chaussade C, Cho K, Mawson C, Rewcastle GW, Shepherd PR (2009) Functional differences between two classes of oncogenic mutation in the PIK3CA gene. Biochem Biophys Res Commun 381(4):577-581
18. Christoforidis S, Miaczynska M, Ashman K, Wilm M, Zhao L, Yip S-C, Waterfield MD, Backer JM, Zerial M (1999) Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nature Cell Biology 1:249-252 (Pubitemid 129500945)
19. Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C, Azzolino O, Gonella C, Rubinetto C, Wu H, Dastru W, Martin EL, Silengo L, Altruda F, Turco E, Lanzetti L, Musiani P, Ruckle T, Rommel C, Backer JM, Forni G, Wymann MP, Hirsch E (2008) Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 1(36):ra3
20. Cuevas BD, Lu Y, Mao M, Zhang J, LaPushin R, Siminovitch K, Mills GB (2001) Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J Biol Chem 276(29):27455-27461
21. Czupalla C, Culo M, Muller EC, Brock C, Reusch HP, Spicher K, Krause E, Nurnberg B (2003) Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 278(13):11536-11545 (Pubitemid 36792715)
22. Denley A, Kang S, Karst U, Vogt PK (2008) Oncogenic signaling of class I PI3K isoforms. Oncogene 27(18):2561-2574 (Pubitemid 351550883)
23. Deora AA, Win T, Vanhaesebroeck B, Lander HM (1998) A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 30-kinase to Ras by redox stress. J Biol Chem 273 (45):29923-29928 (Pubitemid 28510008)
24. Dey BR, Furlanetto RW, Nissley SP (1998) Cloning of human p55 gamma, a regulatory subunit of phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor. Gene 209(1-2):175-183 (Pubitemid 28149632)
25. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonezawa K, Kasuga M, Waterfield MD (1994a) PI 3-kinase: Structural and functional analysis of intersubunit interactions. EMBO J 13:511-521 (Pubitemid 24050665)
26. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, Kasuga M, Courtneidge SA, Waterfield MD (1994b) PI 3-kinase is a dual specificity enzyme: Autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13:522-533 (Pubitemid 24050666)
27. Diekmann D, Brill S, Garrett MD, Totty N, Hsuan J, Monfries C, Hall C, Lim L, Hall A (1991) Bcr encodes a GTPase-activating protein for p21-rac. Nature 351:400-402 (Pubitemid 21896606)
28. Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7(8):606-619 (Pubitemid 44100518)
29. Escobedo JA, Navankasattusas S, Kavanaugh WM, Milfay D, Fried VA, Williams LT (1991) cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell 65(1):75-82 (Pubitemid 121001215)
30. Fantl WJ, Escobedo JA, Martin GA, Turck CW, del Rosario M, McCormick F, Williams LT (1992) Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules that Mediate Different Signalling Pathways. Cell 69:413-423
31. Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, Gish G, Shoelson SE, Pawson T, Forman-Kay JD, Kay LE (1994) Backbone dynamics of a free and phosphopeptidecomplexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (Mosc) 33(19):5984-6003 (Pubitemid 24184605)
32. Foukas LC, Beeton CA, Jensen J, Phillips WA, Shepherd PR (2004) Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. Mol Cell Biol 24(3):966-975 (Pubitemid 38112162)
33. Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ, Withers DJ, Vanhaesebroeck B (2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441(7091):366-370 (Pubitemid 44050203)
34. Fruman DA (2007) The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity. Biochem Soc Trans 35(Pt 2):177-180 (Pubitemid 46596461)
35. Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, Bronson RT, Kahn CR, Cantley LC (2000) Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 26(3):379-382
36. Fu Z, Aronoff-Spencer E, Backer JM, Gerfen GJ (2003) The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling. Proc Natl Acad Sci USA 100(6):3275-3280 (Pubitemid 36356573)
37. Fu Z, Aronoff-Spencer E, Wu H, Gerfen GJ, Backer JM (2004) The iSH2 domain of PI 3-kinase is a rigid tether for p110 and not a conformational switch. Arch Biochem Biophys 432(2):244-251 (Pubitemid 39470020)
38. Fushman D, Xu R, Cowburn D (1999) Direct determination of changes of interdomain orientation on ligation: use of the orientational dependence of 15N NMR relaxation in Abl SH(32). Biochemistry (Mosc) 38(32):10225-10230
39. Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 104(19):7809-7814 (Pubitemid 47185833)
40. Gout I, Dhand R, Panayotou G, Fry MJ, Hiles I, Otsu M, Waterfield MD (1992) Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system. Biochem J 288(Pt 2):395-405
41. Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, Smith AJ, Okkenhaug K, Vanhaesebroeck B (2008) The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA 105(24):8292-8297 (Pubitemid 351904749)
42. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H (1995) Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol 129(3):831-842
43. Günther UL, Liu YX, Sanford D, Bachovchin WW, Schaffhausen B (1996) NMR analysis of interactions of a phosphatidylinositol 30-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites. Biochemistry 35:15570-15581 (Pubitemid 26408895)
44. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J (2007) Binding of ras to phosphoinositide 3-kinase p110alpha is required for rasdriven tumorigenesis in mice. Cell 129(5):957-968 (Pubitemid 46802703)
45. Gymnopoulos M, Elsliger MA, Vogt PK (2007) Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci USA 104(13):5569-5574 (Pubitemid 47175721)
46. Hale BG, Batty IH, Downes CP, Randall RE (2008) Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem 283(3):1372-1380
47. Herbst JJ, Andrews G, Contillo L, Lamphere L, Gardner J, Lienhard GE, Gibbs EM (1994) Potent activation of phosphatidylinositol 30-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry 33:9376-9381 (Pubitemid 24272892)
48. Hiles ID, Otsu M, Volinia S, Fry MJ, Gout I, Dhand R, Panayotou G, Ruiz-Larrea F, Thompson A, Totty NF, Hsuan JJ, Courtneidge SA, Parker PJ, Waterfield MD (1992) Phosphatidylinositol 3-Kinase: Structure and Expression of the 110 kd Catalytic Subunit. Cell 70:419-429
49. Hoedemaeker FJ, Siegal G, Roe SM, Driscoll PC, Abrahams JP (1999) Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate. J Mol Biol 292(4):763-770 (Pubitemid 29465471)
50. Holt KH, Olson AL, Moye-Rowley WS, Pessin JE (1994) Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits. Mol Cell Biol 14:42-49
51. Horn S, Bergholz U, Jucker M, McCubrey JA, Trumper L, Stocking C, Basecke J (2008) Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells. Oncogene 27(29):4096-4106 (Pubitemid 351931986)
52. Hu P, Schlessinger J (1994) Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta. Mol Cell Biol 14(4):2577-2583
53. Hu P, Mondino A, Skolnik EY, Schlessinger J (1993) Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol Cell Biol 13:7677-7688 (Pubitemid 23354292)
54. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT (1995) Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268(5207): 100-102
55. Huang CH, Mandelker D, Schmidt-Kittler O, Samuels Y, Velculescu VE, Kinzler KW, Vogelstein B, Gabelli SB, Amzel LM (2007) The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 318(5857): 1744-1748 (Pubitemid 350274378)
56. Ikenoue T, Kanai F, Hikiba Y, Obata T, Tanaka Y, Imamura J, Ohta M, Jazag A, Guleng B, Tateishi K, Asaoka Y, Matsumura M, Kawabe T, Omata M (2005) Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65(11):4562-4567 (Pubitemid 40740791)
57. Imai Y, Clemmons DR (1999) Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology 140(9):4228-4235 (Pubitemid 30647121)
58. Inukai K, Anai M, Van Breda E, Hosaka T, Katagiri H, Funaki M, Fukushima Y, Ogihara T, Yazaki Y, Kikuchi YO, Asano T (1996) A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK Is generated by alternative splicing of the p85alpha gene. J Biol Chem 271(10):5317-5320
59. Inukai K, Funaki M, Nawano M, Katagiri H, Ogihara T, Anai M, Onishi Y, Sakoda H, Ono H, Fukushima Y, Kikuchi M, Oka Y, Asano T (2000) The N-terminal 34 residues of the 55 kDa regulatory subunits of phosphoinositide 3-kinase interact with tubulin. Biochem J 346 (Pt 2):483-489 (Pubitemid 30148137)
60. Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS (2005) Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res 65(23):10992-11000 (Pubitemid 41713369)
61. Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhari S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman K, Lorenzo M, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker J, de Sauvage FJ, Backer JM, Seshagiri S (2009) Somatic mutations in p85a promote tumorigenesis through class IA PI3K activation. Cancer Cell 16(6):463-474
62. Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, Zhang J, Signoretti S, Loda M, Roberts TM, Zhao JJ (2008) Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454(7205):776-779
63. Jimenez C, Jones DR, Rodríguez-Viciana P, Gonzalez-García A, Leonardo E, Wennström S, Von Kobbe C, Toran JL, Borlado LR, Calvo V, Copin SG, Albar JP, Gaspar ML, Diez E, Marcos MAR, Downward J, Martinez C, Mérida I, Carrera AC (1998) Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 17:743-753 (Pubitemid 28062053)
64. Jimenez C, Hernandez C, Pimentel B, Carrera AC (2002) The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J Biol Chem 277 (44):41556-41562 (Pubitemid 35257459)
65. Jucker M, Sudel K, Horn S, Sickel M, Wegner W, Fiedler W, Feldman RA (2002) Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO). Leukemia 16(5):894-901 (Pubitemid 34537563)
66. Kang S, Bader AG, Vogt PK (2005) Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102(3):802-807 (Pubitemid 40282746)
67. Kang S, Denley A, Vanhaesebroeck B, Vogt PK (2006) Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci USA 103(5):1289-1294 (Pubitemid 43191158)
68. Kapeller R, Prasad KVS, Janssen O, Hou W, Schaffhausen BS, Rudd CE, Cantley LC (1994) Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. J Biol Chem 269:1927-1933
69. Klippel A, Escobedo JA, Hu Q, Williams LT (1993) A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol Cell Biol 13:5560-5566 (Pubitemid 23260658)
70. Klippel A, Escobedo JA, Hirano M, Williams LT (1994) The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol 14(4):2675-2685 (Pubitemid 24108249)
71. Klippel A, Reinhard C, Kavanaugh WM, Apell G, Escobedo MA, Williams LT (1996) Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signaltransducing kinase pathways. Mol Cell Biol 16:4117-4127 (Pubitemid 26251211)
72. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM (2006) A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125(4):733-747
73. Kodaki T, Woscholski R, Hallberg B, Rodriguez-Viciana P, Downward J, Parker PJ (1994) The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol 4:798-806
74. Koyama S, Yu H, Dalgarno DC, Shin TB, Zydowsky LD, Schreiber SL (1993) Structure of the Pl3K SH3 domain and analysis of the SH3 family. Cell 72:945-952 (Pubitemid 23110235)
75. Kubo H, Hazeki K, Takasuga S, Hazeki O (2005) Specific role for p85/p110beta in GTP-bindingprotein-mediated activation of Akt. Biochem J 392(Pt 3):607-614 (Pubitemid 43022741)
76. Kurosu H, Maehama T, Okada T, Yamamoto T, Hoshino S, Fukui Y, Ui M, Hazeki O, Katada T (1997) Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110b is synergistically activated by the bgamma subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 272:24252-24256 (Pubitemid 27418626)
77. Layton MJ, Harpur AG, Panayotou G, Bastiaens PIH, Waterfield MD (1998) Binding of a diphosphotyrosine-containing peptide that mimics activated platelet-derived growth factor receptor b induces oligomerization of phosphatidylinositol 3-kinase. J Biol Chem 273(50):33379-33385
78. Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8(8):627-644
79. Maier U, Babich A, Nürnberg B (1999) Roles of non-catalytic subunits in Gbgamma-induced activation of class I phosphoinositide 3-kinase isoforms b and gamma. J Biol Chem 274 (41):29311-29317
80. Mandelker D, Gabelli SB, Schmidt-Kittler O, Zhu J, Cheong I, Huang CH, Kinzler KW, Vogelstein B, Amzel LM (2009) A frequent kinase domain mutation that changes the interaction between PI3K{alpha} and the membrane. Proc Natl Acad Sci USA 106: 16996-17001
81. Marone R, Cmiljanovic V, Giese B, Wymann MP (2008) Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 1784(1):159-185
82. Matsuda M, Mayer BJ, Hanafusa H (1991) Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine- containing proteins. Mol Cell Biol 11(3):1607-1613 (Pubitemid 21895518)
83. Mayer BJ, Jackson PK, Baltimore D (1991) The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc Natl Acad Sci USA 88(2):627-631 (Pubitemid 21915519)
84. Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y, Schneidman-Duhovny D, Wolfson HJ, Backer JM, Williams RL (2007) Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317(5835):239-242 (Pubitemid 47076198)
85. Moran MF, Koch CA, Anderson D, Ellis C, England L, Martin GS, Pawson T (1990) Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA 87(21):8622-8626
86. Murga C, Fukuhara S, Gutkind JS (2000) A novel role for phosphatidylinositol 3-kinase b in signaling from G protein-coupled receptors to Akt. J Biol Chem 275(16):12069-12073 (Pubitemid 30237781)
87. Musacchio A, Cantley LC, Harrison SC (1996) Crystal structure of the breakpoint cluster region homology domain from phosphoinositide 3-kinase p85a subunit. Proc Natl Acad Sci USA 93:14373-14378 (Pubitemid 26418973)
88. Nolte RT, Eck MJ, Schlessinger J, Shoelson SE, Harrison SC (1996) Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat Struct Biol 3(4):364-374
89. O'Brien R, Rugman P, Renzoni D, Layton M, Handa R, Hilyard K, Waterfield MD, Driscoll PC, Ladbury JE (2000) Alternative modes of binding of proteins with tandem SH2 domains. Protein Sci 9(3):570-579 (Pubitemid 30171648)
90. Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F, Panayotou G, Thompson A, Dhand R, Hsuan J, Totty N, Smith AD, Morgan SJ, Courtneidge SA, Parker PJ, Waterfield MD (1991) Characterization of two 85 kD proteins that associate with receptor tyrosine kinases, middle-T/pp 60c-src complexes and PI3-kinase. Cell 65:91-104 (Pubitemid 121001217)
91. Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF, Williams RL (2000) Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103(6):931-943
92. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr., Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, RigginsGJ, BignerDD,Karchin R, Papadopoulos N, Parmigiani G,Vogelstein B, VelculescuVE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807-1812
93. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ, Phillips WA (2001) The phosphatidylinositol 30-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61(20):7426-7429 (Pubitemid 32995029)
94. Pleiman CM, Hertz WM, Cambier JC (1994) Activation of phosphatidylinositol-30 kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263:1609-1612
95. Ramjaun AR, Downward J (2007) Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 6(23):2902-2905
96. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J (1996) Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J 15:2442-2451 (Pubitemid 26151184)
97. Rommel C, Camps M, Ji H (2007) PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 7(3):191-201
98. Rordorf-Nikolic T, Van Horn DJ, Chen D, White MF, Backer JM (1995) Regulation of phosphatidylinositol 30-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem 270:3662-3666
99. Rubio I, Rodriguez-Viciana P, Downward J, Wetzker R (1997) Interaction of Ras with phosphoinositide 3-kinase gamma. Biochem J 326:891-895 (Pubitemid 27438066)
100. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304(5670): 554 (Pubitemid 38541907)
101. Samuels Y, Diaz LA Jr., Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7(6):561-573 (Pubitemid 40799249)
102. Sen KI, Wu H, Backer JM, Gerfen GJ (2010) The Structure of p85ni in Class IA Phosphoinositide 3-Kinase Exhibits Interdomain Disorder. Biochemistry 49:2159-2166
103. Shekar SC, Wu H, Fu Z, Yip SC, Cahill SM, Girvin ME, Backer JM (2005) Mechanism of constitutive PI 3-kinase activation by oncogenic mutants of the p85 regulatory subunit. J Biol Chem 280:27850-27855 (Pubitemid 41076901)
104. Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, Hoepfner S, Wenk MR, Modregger J, Uttenweiler-Joseph S, Wilm M, Nystuen A, Frankel WN, Solimena M, De Camilli P, Zerial M (2005) An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol 170(4):607-618 (Pubitemid 41186935)
105. Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y (2007a) SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol 81(23):12730-12739 (Pubitemid 350156910)
106. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y (2007b) Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88(Pt 1):13-18 (Pubitemid 46085109)
107. Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC (1998) Solution structure of the C-terminal SH2 domain of the p85a regulatory subunit of phosphoinositide 3-kinase. J Mol Biol 276:461-478 (Pubitemid 28085333)
108. Skolnik EY, Margolis B, Mohammadi M, Lowenstein E, Fischer R, Drepps A, Ullrich A, Schlessinger J (1991) Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65:83-90 (Pubitemid 121001216)
109. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778 (Pubitemid 23093884)
110. Stuart D, Sellers WR (2009) Linking somatic genetic alterations in cancer to therapeutics. Curr Opin Cell Biol 21(2):304-310
111. Taylor SS, Kim C, Vigil D, Haste NM, Yang J, Wu J, Anand GS (2005) Dynamics of signaling by PKA. Biochim Biophys Acta 1754(1-2):25-37 (Pubitemid 41797684)
112. Tolias KF, Cantley LC, Carpenter CL (1995) Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 270:17656-17659
113. Vanhaesebroeck B, Higashi K, Raven C, Welham M, Anderson S, Brennan P, Ward SG, Waterfield MD (1999) Autophosphorylation of p110d phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J 18(5):1292-1302 (Pubitemid 29110313)
114. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602 (Pubitemid 32662219)
115. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30(4):194-204 (Pubitemid 40463309)
116. Waksman G, Shoelson SE, Pant N, Cowburn D, Kuriyan J (1993) Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72(5):779-790 (Pubitemid 23093885)
117. Walker EH, Perisic O, Ried C, Stephens L, Williams RL (1999) Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402(6759):313-320 (Pubitemid 129516270)
118. Woscholski R, Dhand R, Fry MJ, Waterfield MD, Parker PJ (1994) Biochemical characterization of the free catalytic p110a and the complexed heterodimeric p110alp85a forms of the mammalian phosphatidylinositol 3-kinase. J Biol Chem 269:25067-25072 (Pubitemid 24311776)
119. WuH, YanY, Backer JM(2007)Regulation of class IA PI3Ks. BiochemSoc Trans 35(Pt 2):242-244 (Pubitemid 46596479)
120. Wu H, Shekar SC, Flinn RJ, El-Sibai M, Jaiswal BS, Sen KI, Janakiraman V, Seshagiri S, Gerfen GJ, Girvin ME, Backer JM (2009) Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants. Proc Natl Acad Sci USA 106(48):20258-20263
121. Wymann MP, Bjorklof K, Calvez R, Finan P, Thomast M, Trifilieff A, Barbier M, Altruda F, Hirsch E, Laffargue M (2003) Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem Soc Trans 31(Pt 1):275-280 (Pubitemid 36241444)
122. Xia X, Cheng A, Akinmade D, Hamburger AW (2003) The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest. Mol Cell Biol 23(5):1717-1725 (Pubitemid 36246052)
123. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM (1998a) Regulation of the p85/p110 phosphatidylinositol 30-kinase: Stabilization and inhibition of the p110-alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379-1387 (Pubitemid 28100902)
124. Yu JH, Wjasow C, Backer JM (1998b) Regulation of the p85/p110a Phosphatidylinositol 30-kinase -Distinct roles for the N-terminal and C-terminal SH2 domains. J Biol Chem 273(46):30199-30203 (Pubitemid 28545483)
125. Zhang W, Smithgall TE, Gmeiner WH (1998) Self-association and backbone dynamics of the hck SH2 domain in the free and phosphopeptide-complexed forms. Biochemistry (Mosc) 37(20):7119-7126 (Pubitemid 28235192)
126. Zhao L, Vogt PK (2008) Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc Natl Acad Sci USA 105(7):2652-2657 (Pubitemid 351520568)
127. Zhao JJ, Liu Z, Wang L, Shin E, Loda MF, Roberts TM (2005) The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells. Proc Natl Acad Sci USA 102(51):18443-18448 (Pubitemid 43011245)
128. Zheng Y, Bagrodia S, Cerione RA (1994) Activation of phosphoinositide 3-kinase by Cdc42Hs binding to p85. J Biol Chem 269:18727-18730 (Pubitemid 24226178)